On Friday, in the course of current trade, Shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX), dropped -1.42%, and is now trading at $238.30.
Valeant Pharmaceuticals International, declared that its wholly owned partner, Salix Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for Xifaxan® 550 mg for the treatment of IBS-D in adults. The FDA approval of Xifaxan 550 mg is based on data from three phase 3 studies, TARGET 1, TARGET 2 and TARGET 3. Xifaxan 550 mg was studied in over 3,000 patients and demonstrated the efficacy and safety of repeat treatment following completion of a two-week course of treatment. A full course of Xifaxan 550 mg for IBS-D is accessible in a convenient 2 week pack of 42 pills.
As many as 35 million adult Americans may experience IBS, and 40% of people with IBS suffer from diarrhea-prominent symptoms that comprise urgency, loose, watery stools and abdominal pain. Although millions suffer from the condition, current treatments for IBS-D are limited to products aimed at relieving individual symptoms (e.g., antispasmodics, anti-diarrheal agents, bulking agents, anti-flatulence agents) and fail to address the syndrome complex.
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, in addition to Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails.
During an Afternoon trade, Shares of Ruckus Wireless, Inc. (NYSE:RKUS), gained 0.47%, and is now trading at $10.70.
Ruckus Wireless, declared the availability of CloudManager for Xclaim, a 100 percent subscription-free cloud service to manage its Xclaim™ family of disruptively priced, cloud-ready, controller-free indoor and outdoor business-class WiFi access points (APs).
The Xclaim product line is a new line of entry-level enterprise WiFi products from Ruckus Wireless, aimed squarely at businesses requiring a cost-effective, industrial-strength solution that bridges the gap between poor performing and featureless consumer-grade products and more costly and sophisticated enterprise class solutions that often require dedicated in-house IT expertise.
Ruckus Wireless, Inc. provides carrier-class Wi-Fi solutions to service providers and enterprises worldwide. It provides gateways, controllers, and access points with related software and services. The company offers SmartCell, a line of carrier-grade wireless access and administration products that comprise specialized hardware products, such as SmartCell Gateways and SmartCell Access Points, in addition to software solutions comprising virtualized SmartCell Gateway and SmartCell Insight software platforms.
Shares of FMC Technologies, Inc. (NYSE:FTI), during its Friday’s current trading session gained 0.05%, and is now trading at $41.94.
FMC Technologies, declared that Maryann Seaman, Executive Vice President and Chief Financial Officer, will address attendees at the following event:
2015 RBC Capital Markets’ Global Energy and Power Executive Conference, on June 1 – 2, 2015, at The Ritz-Carlton New York, Battery Park, Two West Street, New York City, NY 10004.
FMC Technologies, Inc. provides technology solutions for the energy industry worldwide. The company operates through Subsea Technologies, Surface Technologies, and Energy Infrastructure segments.
Finally, Opko Health, Inc. (NYSE:OPK), gained 0.34% Friday.
OPKO Health, declared that senior administration will present at the Jefferies 2015 Healthcare Conference on Wednesday, June 3, 2015 at 4:00 PM EDT in New York City.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
